期刊文献+

老年晚期非小细胞肺癌患者药物治疗现状和趋势 被引量:8

The Status and Prospects of Treatment Protocols for Elderly Patients with Non-small Cell Lung Cancer
在线阅读 下载PDF
导出
摘要 近年来,老年晚期肺癌发病率和死亡率呈明显上升趋势,但老年患者总体接受积极治疗的人数却明显少于非老年患者,同时因受到社会、经济、家庭等医疗以外诸多因素的影响,老年晚期肺癌患者治疗现状不容乐观。现就当前国内外老年非小细胞肺癌患者的治疗现状和趋势作一综述。 In recent years, the incidence and mortality of advanced lung cancer in elderly patients have been in- creasing. However, the general acceptance of treatment more than best supportive care in the elderly patients is not optimistic, because the social-economic, family and other factors besides health care were involved in the treatment strategy. In this review, we summarize the current status and prospect of treatment protocols for elderly patients with non-small cell lung cancer.
出处 《中国肺癌杂志》 CAS 2011年第7期598-605,共8页 Chinese Journal of Lung Cancer
关键词 肺肿瘤 老年患者 治疗现状 Lung neoplasms Elderly patients Treatment status
作者简介 (通讯作者:高蓓莉,E-mail:yushu7661@sina.com)
  • 相关文献

参考文献50

  • 1Ling Yang, Maxwell P, Jacques F, et al. Estimates of cancer incidence in China for 2000 and projections for 2005. Biomarkers Prev, 2005, 14(1): 243-250.
  • 2Owonikoko TK, Ragin CC, Belani CP, et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database.J Clin Oncol, 2007, 25(35): 5570-5577.
  • 3Koumarianou A, Fountzilas G, Kosmidis P, et al. Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patients. J Chemother, 2009, 21(5): 573-583.
  • 4Altundag O, Stewart DJ, Fossella FV, et al. Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy.J "Ihorac Oncol, 2007, 2(2): 141-146.
  • 5Hainsworth JD, Spigel DR, Farley C, et al. Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer: a randomized phase 3 trial of the Minnie Pearl Cancer Research Network. Cancer, 2007, 110(9): 2027-2034.
  • 6Q uoix E, Monnet I, Scheid P, et al. Management and outcome of French elderly patients with lung cancer: an IFCT survey. Rev Mal Respir, 2010, 27 (5): 421-430.
  • 7DavidoffAJ, Tang M, Seal B, et al. Chemotherapy and survival benefit in elderly patients with advanced non-small-ceil lung cancer. J Clin Oncol, 2010, 28(13): 2191-2197.
  • 8Pallis AG, Karampeazis A, Vamvakas L, et al. Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group. Ann Oncol, 2011 Mar 10. [Epub ahead of print].
  • 9Langer CJ, Manola, Bernardo P, et al. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: Implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Nail Cancer Inst, 2002, 94(3): 173-181.
  • 10Ihe Elderly Lung Cancer Vinorelbine Italian Study (ELVIS) Group. Effects ofvinorelbine on qualiW of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst, 1999, 91 (1): 66-72.

二级参考文献21

  • 1孙清,华军,王琦,徐伟,毛永杰.吉西他滨加或不加顺铂治疗老年人晚期非小细胞肺癌的随机对照研究[J].中华老年医学杂志,2006,25(5):354-355. 被引量:7
  • 2Lilenbaum RC, Hemdon J, Marcy L, et al. Single-agent (SA) versus combination chemotherapy (CC) in advanced non-small cell lung cancer (NSCLC): a CALGB randomized trial of efficacy, quality of life (QQL), and cost-effectiveness. Proceeding of ASCO, 2002, Abstract, No: 2.
  • 3Hensing TA, Peterman AH, Schell M J, et al. The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, stage ⅢB or Ⅳ non-small cell lung carcinoma treated with carboplatin and paclitaxel. Cancer, 2003, 98(4): 779-788.
  • 4Langer C J, Manola J, Bernardo P, et al. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Ontology Group 5592, a randomized trial. J Natl Cancer Inst, 2002, 94(3): 173-181.
  • 5Gridelli C, Perrone F, Gallo C, et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase Ⅲ randomized trial. J Natl Cancer Inst, 2003, 95(5): 362-372.
  • 6Lilenbaum RC, Herndon JE 2nd, List MA, et al. Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol, 2005, 23(1): 190-196.
  • 7Hainsworth JD, Burris HA, Litchy S, et al. Weekly docetaxel in the treatment of elderly patients with advanced non-small cell lung carcinoma. A Minnie Pearl Cancer Research Network Phase Ⅱ Trial. Cancer, 2000, 89(2): 328-333.
  • 8Hanna N, Sheperd FA, Fossella FV, et al. Randomized phase m trial of pemetrexed versus docetaxel in patients with non-small cell lung cancer previously treated with chemotherapy. J Clin Oncol, 2004, 22(9): 1589-1597.
  • 9Gridelli C, Perrone F, Monfardini S. Lung cancer in the elderly. Eur J Cancer, 1997, 33: 2313-2314.
  • 10Rigas JR. Taxane-platinum combinations in advanced non-small cell lung cancer: a review. Oncologist, 2004, 9(2): 16-23.

共引文献32

同被引文献84

  • 1罗凤玲,梁卓林,杨蕴,吴煌坚,梁海斯.长春瑞滨为主联合方案治疗中晚期非小细胞肺癌疗效观察[J].广州医药,2005,36(2):52-53. 被引量:1
  • 2刘吉福,李迎春,武姗姗,王昆.晚期肺肿瘤冷冻消融治疗的探讨[J].中国肿瘤临床与康复,2006,13(4):355-357. 被引量:4
  • 3李洪升,李宝生.非小细胞肺癌放射性肺损伤的研究进展[J].中华肿瘤防治杂志,2007,14(18):1437-1439. 被引量:24
  • 4Gridelli C,Perrone F, Monafardini S. Lung cancer in the elderly [J]. Eur J Cancer, 1997,33 : 2313-2314.
  • 5Nyman J, Johansson KA, Hulten U. Stereotactic hypofraction- ated radiotherapy for stage I non-small cell lung cancer-mature results for medically inoperable patients[J]. Lung Cancer,2006, 51(1) :97-103.
  • 6Sirotnak FM. Studies with ZD1839 in preclinical modls[J]. Se- min Oncol,2003,30(Suppl 1) :12-20.
  • 7Ritter CA, Arteaga CL. The epidermal growth factor recep-tor- tyrosine kinase..a promisin therapeutic targei in solid tumors[J]. Semin Oncol, 2003,30(Suppl 1) :3-11.
  • 8Chang A,Parikh P, Thongprasert S,et al. Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study[J]. J Thorac Oncol, 2006,1(8) : 847-855.
  • 9Chen Gy, Jiang GL,QianH, et al . Escalated hyperfractionated accelerated radiation therapyfor locallyacvanced non-small cell lung cancer: a clinical pyase O trial[J]. Radiother Oncel, 2004, 71: 157-162.
  • 10Fairchild A, Harris K, Barnes E, et al. Palliative thoracic ra- diotherapy or lung cancer: a systematic review[J]. J Clin On- col, 2008,26:4001-4011.

引证文献8

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部